Vcanbio Capital Management LLC, founded in 2017, is currently managing the “Vcanbio USA Healthcare Venture Fund” (the Fund) of US $40 million. The Fund invested in several startup biotech companies founded by professors from Harvard, MIT, and Yale University.
